GetTopicDetailResponse(id=9ca4163354d, topicName=siRNA藥物, introduction=siRNA藥物, content=null, image=null, comments=3, allHits=893, url=https://h5.medsci.cn/topic?id=16335, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98594, tagList=[TagDto(tagId=98594, tagName=siRNA藥物)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1794110, encodeId=beae1e94110ec, content=<a href='/topic/show?id=9ca4163354d' target=_blank style='color:#2F92EE;'>#siRNA藥物#</a>, objectTitle=FDA批準vutrisiran治療成人遺傳性轉甲狀腺素蛋白淀粉樣變性伴多發(fā)性神經病（hATTR-PN），這是第5款siRNA藥物, objectType=article, longId=729775, objectId=6f41e29775b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f41e29775b5, replyNumber=0, likeNumber=109, createdTime=2022-12-04, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f41e29775b5, moduleTitle=FDA批準vutrisiran治療成人遺傳性轉甲狀腺素蛋白淀粉樣變性伴多發(fā)性神經病（hATTR-PN），這是第5款siRNA藥物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6f41e29775b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1794109, encodeId=af071e9410999, content=<a href='/topic/show?id=9ca4163354d' target=_blank style='color:#2F92EE;'>#siRNA藥物#</a>, objectTitle=美國FDA延遲批準諾華的siRNA藥物inclisiran, objectType=article, longId=204702, objectId=1eb3204e028a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1eb3204e028a, replyNumber=0, likeNumber=97, createdTime=2021-02-28, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1eb3204e028a, moduleTitle=美國FDA延遲批準諾華的siRNA藥物inclisiran, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1eb3204e028a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1794108, encodeId=d1681e9410860, content=<a href='/topic/show?id=9ca4163354d' target=_blank style='color:#2F92EE;'>#siRNA藥物#</a>, objectTitle=諾華97億收購的PCSK9的siRNA藥物inclisiran，預計將于2020年批準上市, objectType=article, longId=185939, objectId=005818593917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=005818593917, replyNumber=0, likeNumber=78, createdTime=2020-04-08, rootId=0, userName=wmr111, userId=a8f1167, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=005818593917, moduleTitle=諾華97億收購的PCSK9的siRNA藥物inclisiran，預計將于2020年批準上市, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=005818593917)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
